Qube Research & Technologies LTD Passage Bio, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.66 - $1.01 $2 - $4	4 New	4 $0
Q3 2022 Nov 14, 2022	SELL	$1.22 - $2.48 $4,610 - $9,371	-3,779 Reduced 11.14%	30,129 $38,000
Q2 2022 Aug 15, 2022	BUY	$1.63 - $3.46 $55,270 - $117,321	33,908 New	33,908 $80,000
Q4 2021 Feb 01, 2022	SELL	$6.24 - $10.2 $144,225 - $235,752	-23,113 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.73 - $15.52 $224,889 - $358,713	23,113 New	23,113 $230,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.